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ABSTRACT
Introduction: Estrogen defi ciency leads to bone mass loss and increased risk for osteoporosis. The aim 
of this study was to examine infl uence of cigarette smoking on bone mineral density in postmenopausal 
women with estrogen defi ciency in menstrual history.
Methods: The total of 100 postmenopausal women living in Sarajevo area, aged 50-65 years, with es-
trogen defi ciency in menstrual history participated in this prospective study. The subjects were divided in 
two groups, examination and control group, based on bone mineral density values. The women in the 
examination group had osteoporosis while in the control group were women with osteopenia or normal 
bone mineral density. Bone mineral density was measured at the lumbar spine and proximal femur by 
Dual–Energy X–ray Absorptiometry using Hologic QDR-4000 scanner. Smoking habits were assessed for 
each subject.
Results: The average number of cigarettes smoked per day in women with estrogen defi ciency in men-
strual history was 14.86 in the examination group and 4.67 in the control group. The difference in the 
average number of cigarettes smoked per day between the two groups was statistically signifi cant (p 
<0.01). The coeffi cient of linear correlation between T score and the number of cigarettes smoked per day 
among women with estrogen defi ciency in menstrual history in the examination group was statistically 
signifi cant (p<0.01). The coeffi cient of linear correlation between T score and the number of cigarettes 
smoked per day among women with estrogen defi ciency in menstrual history in the control group was 
statistically signifi cant ( p<0.05).
Conclusion: Results of this study suggest that cigarette smoking has negative impact on bone mineral 
density and that healthy lifestyle (no smoking) has the potential to reduce bone loss in postmenopausal 
women with estrogen defi ciency in menstrual history.
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INTRODUCTION
Osteoporosis is a skeletal disorder characterized by 
compromised bone strength (bone strength primar-
ily refl ects the integration of bone density; bone 
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quality refers to architecture, metabolic turnover, 
damage accumulation and demineralization) predis-
posing a person to an increased risk of fracture (1). 
Th e pathogenesis of osteoporosis include: failure to 
achieve a skeleton of optimal strength during growth 
and development, excessive bone resorption result-
ing in loss of bone mass and disruption of architec-
ture and failure to replace lost bone due to defects 
in bone formation (2). Sex steroids (estrogens and 
androgens) slow the rate of bone remodeling and 
protect against bone loss acting on osteoclastogen-
esis and osteoblastogenesis, osteoblast and osteocyte 
apoptosis (3). Estrogen defi ciency increases the rate 
of remodeling and increases imbalance in the bone 
multicellular unit resulting in bone loss and struc-
tural decay after menopause (4). A premature meno-
pause, particularly when surgically induced before 
age 45 years, is strong determinant of bone density 
and increased risk of fracture (5). Late menarche is 
also associated with low bone mineral density (6,7). 
Th e later the menarche and the earlier the meno-
pause, the higher the degree of osteoporosis (7). 
Cigarette smoking aff ects the bone duo direct toxic 
eff ects on osteoblasts/osteoclasts activity of nicotine, 
and indirect actions on sex and adrenocortical hor-
mones, vitamin D, intestinal calcium absorption, 
vessels and oxygen supply (8). Smoking aff ects pi-
tuitary, thyroid, adrenal, testicular and ovarian func-
tion, calcium metabolism and the action of insulin 
and the major salient clinical eff ects are the increased 
risk and severity of Graves’ hyperthyroidism and op-
thalmopathy, osteoporosis and reduced fertility (9). 
Some normal, estrogen-dependent physiologic pro-
cesses are aff ected by smoking, making osteoporosis 
and premature menopause more common among 
women who smoke (10). Smoking reduces the pro-
duction of estrogen by the ovaries, causing changes 
in hepatic estrogen metabolism, showed toxic eff ects 
on ovarian follicles and the bone cells, reduces the 
conversion of androgen into estrogen, the concen-
tration of sex hormone binding globulin (SHBG), 
which binds circulation estrogens, is higher in wom-
en who smoke, and lower concentrations of the bio-
logically active estrogens (9, 11, 12). Th e aim of this 
study was to examine infl uence of cigarette smoking 
on bone mineral density in postmenopausal women 
with estrogen defi ciency in menstrual history. 
METHODS
Th e total of 100 postmenopausal women living in 
Sarajevo area, aged 50-65 years, with estrogen de-
fi ciency in menstrual history participated in this 
prospective study. Th e subjects were divided in two 
groups, examination and control group, based on 
bone mineral density values. Th e women in the 
examination group (n=50) had osteoporosis. Th e 
women in the control group (n=50) had osteopenia 
or normal bone mineral density. Bone mineral den-
sity was measured at the lumbar spine and proximal 
femur by Dual–Energy X–ray Absorptiometry using 
Hologic QDR-4000 scanner. Smoking habits were 
assessed for each subject. Th e inclusion criteria were: 
postmenopausal women with estrogen defi ciency 
in menstrual history (fewer than 30 years of men-
struation, menopause before age 45 years), women 
aged 50-65 years, women who live in the Sarajevo 
area, women who do not use hormone replacement 
therapy, women whose fi nding's of bone densitom-
etry was at the level of osteoporosis, women whose 
fi nding's of bone densitometry was at the level of 
osteopenia or normal. Th e exclusion criteria were: 
postmenopausal women without estrogen defi -
ciency in menstrual history, women younger than 
50 and older than 65 years, women who do not 
live in the Sarajevo area, women who are not post-
menopausal, women who use hormone replacement 
therapy, women who have a disease that can cause 
osteoporosis, women who use drugs that may cause 
osteoporosis.
Statistical analysis
Th e results were statistically analyzed. Statistical sig-
nifi cance between examination and control group in 
cigarette smoking was tested by Student's t-test. Th e 
coeffi  cient of linear correlation between cigarette 
smoking and bone mineral density was calculated. P 
< 0.05 was considered statistically signifi cant.
RESULTS
Th e average age of women with estrogen defi ciency 
in their menstrual history in the examination group 
was 58.48 years, and in the control group was 57.30 
years. Th ere was no statistically signifi cant diff er-
ences between these two groups, t = 1.169.
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Th e average number of cigarettes smoked per day in 
women with estrogen defi ciency in menstrual his-
tory stood at 14.86 in the examination group and in 
the control group 4.67. Th e diff erence in the aver-
age number of cigarettes smoked per day between 
the two groups was statistically signifi cant, t = 6.009, 
p < 0.01.
Th e coeffi  cient of linear correlation between T scores 
and the number of cigarettes smoked per day among 
women with estrogen defi ciency in menstrual his-
tory in the examination group was statistically sig-
nifi cant, r = - 0.671; p < 0.01. Th e coeffi  cient of 
linear correlation between T scores and the number 
of cigarettes smoked per day among women with 
estrogen defi ciency in menstrual history in the con-
trol group was statistically signifi cant, r = - 0.350; 
p < 0.05.
DISCUSSION
Estrogen defi ciency leads to bone mass loss and 
increased risk for osteoporosis. Late menarche and 
early menopause are associated with bone loss. Th e 
objective of the study of Parker et al. was to inves-
tigate the association between age at menarche, age 
at menopause, and years of menstruation with inci-
dence of osteoporosis and assess the impact of prena-
tal exposure to diethylstilbestrol (DES), a synthetic 
estrogen, on such associations. Th e results support 
the hypothesis that lifetime cumulative exposure to 
estrogens is protective against osteoporosis (6). Th e 
results of the study of Li et al. showed signifi cant 
increase in osteoporosis of lumbar spine in women 
with the age of menarche > or = 17 compared with 
women with age of menarche < or = 13. Among all 
women aged between 55 – 65, there was signifi cant 
increase in osteoporosis in women with the meno-
pause age < or = 48, compared with the menopause 
age > or = 54 (7). In our previous study we evaluated 
the infl uence of menstrual factors (years between 
menarche and menopause, years since menopause) 
on bone mass loss in Bosnian postmenopausal wom-
en. Average years between menarche and meno-
pause in women with osteoporosis was signifi cant 
lower than in women in control group (osteope-
nia or normal mineral bone density values). Aver-
age years since menopause was signifi cant higher 
Parameters Examination group A
Control 
group A
The coeffi cient of 
linear correlation 
r = - 0.671
p < 0.01
r = - 0.350
p < 0.05
TABLE 1.  The coeffi cient of linear correlation between T 
scores and the number of cigarettes smoked per day among 
women with estrogen defi ciency in menstrual history
FIGURE 1.  The average age of women with estrogen defi -
ciency in menstrual history. t = 1,169; no statistically signifi -
cant
FIGURE 2.  The average number of cigarettes smoked per 
day among women with estrogen defi ciency in menstrual his-
tory (p < 0.01)
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in women with osteoporosis than in women with 
osteopenia or normal bone mineral density values 
(13). Meta-analyses on the eff ects of smoking on 
the bone revealed that current smokers sustained 
decreased bone mass and increased fracture risk at 
age 50 years and older (14). Numerous studies point 
to the negative eff ects of smoking on bone tissue. 
Giampietro  et al. assessed the relative impact of cig-
arette smoking, statin use, genetic polymorphisms, 
and one-way interaction of these factors on devel-
opment of osteoporosis in postmenopausal women. 
Th e results suggested a role for genetic variation in 
the interleukin 6 (IL6) and the lipoprotein receptor-
related protein 5 (LRP5) in conferring risk for osteo-
porosis in Caucasian women, with the latter mani-
fest only in smokers (15). Ward and Klesges studied 
cross-sectional and prospective human studies that 
provided a quantitative measure of bone mass (X-
ray, absorptiometry, or computed tomography) as 
a function of cigarette smoking exposure. Smokers 
had signifi cantly reduced bone mass compared with 
nonsmokers (never and former smokers) at all bone 
sites. Overall, eff ects were greatest in men and in 
the elderly, and were dose-dependent. In prospec-
tive studies, smokers had greater rates of bone loss 
over time compared with nonsmokers. Absolute ef-
fect sizes at most bone sites were greatest for current 
smokers compared with never smokers, intermediate 
for current smokers compared with former smokers, 
and lowest for former smokers compared with never 
smokers, suggesting that smoking cessation may 
have a positive infl uence on bone mass (16). Brook 
et al. assessed how diff erent trajectories of women's 
smoking, covering the ages 40 to 48 years, relate to 
osteoporosis at age 65. Th e chronic/heavy smokers 
were signifi cantly more likely than the non-smokers 
to report having osteoporosis. Quitters and moder-
ate smokers did not diff er signifi cantly from non-
smokers on the osteoporosis measure (17). Th e as-
sociation between secondhand smoke exposure and 
lumbar and femoral neck osteoporosis was assessed 
in postmenopausal never-smoking Korean women 
in the study of Kim et al. Th e fi nding of the study 
was that in postmenopausal never-smoking Korean 
women, exposure to secondhand smoke was posi-
tively associated with osteoporosis (18). Jenkins and 
Denison found that former and current smoking 
increased the risk of hip fracture in population of 
postmenopausal women living in rural and urban 
areas of Northwest Texas (19). In the study of Cum-
mins et al. showed that although hereditary factors 
strongly contribute to bone health, behavioural fac-
tors can modulate the genetically determined pat-
tern of skeletal modelling and remodelling. Smoking 
was the strongest behavioural predictor of lumbar 
and femoral bone mineral density in pre- and post-
menopausal adult Irish women (20). Th e aim of the 
present study was to examine infl uence of cigarette 
smoking on bone mineral density in postmenopaus-
al women, aged 50-65 years living in Sarajevo area 
with estrogen defi ciency in their menstrual history. 
Th e results showed that smoking has a negative eff ect 
on bone mineral density in postmenopausal women, 
aged 50-65 years living in Sarajevo area with estro-
gen defi ciency in their menstrual history. Th e aver-
age number of cigarettes smoked per day in women 
with estrogen defi ciency in menstrual history stood 
at 14.86 in the group of women with osteoporosis 
and in the group of women without osteoporosis 
4.67. Th e diff erence in the average number of ciga-
rettes smoked per day between the two groups was 
statistically signifi cant (p < 0.01). Th e coeffi  cient of 
linear correlation between T scores and the number 
of cigarettes smoked per day among women with 
estrogen defi ciency in menstrual history was statisti-
cally signifi cant in the group of women with osteo-
porosis (p < 0.01) and in the group of women with-
out osteoporosis (p < 0.05). It was shown that the 
negative eff ects of smoking on bone mineral density 
are dose-dependent. Th e defi cit of estrogen is as-
sociated with a decrease in bone mass, but healthy 
lifestyle (no smoking) has the potential to preserve 
bone mass in postmenopausal women with estrogen 
defi ciency in their menstrual history. Encourage-
ment of lifestyle alterations, including smoking ces-
sation, should be a major component of any bone 
therapeutic programme (21). 
CONCLUSION
Th e results of this study suggest that cigarette smok-
ing has infl uence on bone mineral density and in-
creases bone loss in postmenopausal women, aged 
50-65 years living in Sarajevo area, with estrogen de-
fi ciency in their menstrual history. Further healthy 
lifestyle (no smoking) has positive impact on bone 
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in postmenopausal women with estrogen defi ciency 
in their menstrual history.
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